Advertisement
Canada markets close in 1 hour 18 minutes

  • S&P/TSX

    21,866.84
    -144.88 (-0.66%)
     

  • S&P 500

    5,065.35
    -5.20 (-0.10%)
     

  • DOW

    38,455.62
    -48.07 (-0.12%)
     

  • CAD/USD

    0.7295
    -0.0025 (-0.34%)
     

  • CRUDE OIL

    82.89
    -0.47 (-0.56%)
     

  • Bitcoin CAD

    88,722.27
    -2,706.89 (-2.96%)
     

  • CMC Crypto 200

    1,398.48
    -25.62 (-1.80%)
     

  • GOLD FUTURES

    2,333.20
    -8.90 (-0.38%)
     

  • RUSSELL 2000

    1,991.44
    -11.20 (-0.56%)
     

  • 10-Yr Bond

    4.6600
    +0.0620 (+1.35%)
     

  • NASDAQ

    15,685.64
    -11.00 (-0.07%)
     

  • VOLATILITY

    15.96
    +0.27 (+1.72%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6822
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Here's Why Amyris Stock Rose as Much as 12.2% Today

Maxx Chatsko, The Motley Fool
·3 min read
Here's Why Amyris Stock Rose as Much as 12.2% Today

Shares of Amyris (NASDAQ: AMRS) gained over 12% today after the company announced it had signed a binding term sheet with the Infectious Disease Research Institute (IDRI) to collaborate on a SARS-CoV-2 vaccine candidate. Specifically, IDRI will develop a vaccine candidate based on its RNA vaccine platform, while Amyris will supply squalene for use in the vaccine adjuvant.

Continue reading